These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 2984605

  • 1. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G, Giacchino F, Jeantet A, Del Piano A, Garetto A, Pellerey M, Piccoli G.
    Minerva Med; 1985 Mar 10; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract] [Full Text] [Related]

  • 2. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
    Zucchi C.
    Minerva Med; 1985 Mar 10; 76(9-10):397-401. PubMed ID: 3982697
    [No Abstract] [Full Text] [Related]

  • 3. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S, Viganò MR, Beretta P, Rosa M, d'Amico P, Lomuscio G, Paesani R.
    Minerva Med; 1985 Mar 10; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract] [Full Text] [Related]

  • 4. Fluoride and dialysis osteodystrophy: results of a double-blind study.
    Oreopoulos DG, Taves DR, Rabinovich S, Meema HE, Murray T, Fenton SS, deVeber GA.
    Trans Am Soc Artif Intern Organs; 1974 Mar 10; 20A():203-8. PubMed ID: 4615422
    [No Abstract] [Full Text] [Related]

  • 5. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis].
    Bagon J, Brunfaut C.
    J Radiol Electrol Med Nucl; 1974 Jan 10; 55(1):35-9. PubMed ID: 4831994
    [No Abstract] [Full Text] [Related]

  • 6. Osteodystrophy of dialysed patients treated with vitamin D.
    Verberckmoes R, Bouillon R, Krempien B.
    Proc Eur Dial Transplant Assoc; 1973 Jan 10; 10(0):217-26. PubMed ID: 4370246
    [No Abstract] [Full Text] [Related]

  • 7. [Sevelamer hydrochloride and K/DOQI guidelines].
    Yumita S.
    Clin Calcium; 2005 Sep 10; 15 Suppl 1():180-4. PubMed ID: 16279022
    [No Abstract] [Full Text] [Related]

  • 8. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G, Bernardi A, Biasia F, Milan G, Donato D.
    Minerva Med; 1985 Mar 10; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract] [Full Text] [Related]

  • 9. [Surgical treatment of secondary hyperparathyroidism].
    D'Alonzo U.
    Minerva Med; 1985 Mar 10; 76(9-10):389-91. PubMed ID: 3982695
    [No Abstract] [Full Text] [Related]

  • 10. [Prevention and treatment of renal osteodystrophy: present and future].
    Fernández E, Craver L.
    Nefrologia; 2006 Mar 10; 26 Suppl 3():19-27. PubMed ID: 17469423
    [No Abstract] [Full Text] [Related]

  • 11. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia.
    Fukagawa M, Kurokawa K.
    J Nutr Sci Vitaminol (Tokyo); 1992 Mar 10; Spec No():96-9. PubMed ID: 1338454
    [Abstract] [Full Text] [Related]

  • 12. Renal osteodystrophy in children: the effect of hemodialysis and renal homotransplantation.
    Fine RN, Isaacson AS, Payne V, Grushkin CM.
    J Pediatr; 1972 Feb 10; 80(2):243-9. PubMed ID: 4550451
    [No Abstract] [Full Text] [Related]

  • 13. [Therapeutic indications obtained from short- and medium-term biohumoral changes after parathyroidectomy].
    Sforzini S, Viganò MR, Rosa M, Redaelli B.
    Minerva Med; 1985 Mar 10; 76(9-10):393-6. PubMed ID: 3982696
    [No Abstract] [Full Text] [Related]

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 10; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 15. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
    Rahamimov R, Silver J.
    Isr J Med Sci; 1994 Jan 10; 30(1):26-31. PubMed ID: 8138394
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
    Di Landro D, Zanatta GP, Simioni N, Pinzani A, Zotti D, Perin N, Bertoli M, Naso A, Ruffatti A, Gasparotto ML.
    Minerva Med; 1985 Mar 10; 76(9-10):419-23. PubMed ID: 3982699
    [No Abstract] [Full Text] [Related]

  • 17. [Parathyroidectomy for secondary hyperparathyroidism in renal insufficiency].
    Corvilain J, Fuss M, Kinnaert P, Moermans JP, Toussaint C, Van Geertruyden JV, Vereerstraeten P.
    J Urol Nephrol (Paris); 1976 Mar 10; 82(4-5):362-7. PubMed ID: 781303
    [No Abstract] [Full Text] [Related]

  • 18. Indications for parathyroidectomy in patients with chronic renal failure.
    Finch T, Jacobs JK.
    Am Surg; 1974 Jan 10; 40(1):40-4. PubMed ID: 4808621
    [No Abstract] [Full Text] [Related]

  • 19. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T, Garzoni D, Staub T, Binet I, Wüthrich RP.
    Kidney Blood Press Res; 2006 Jan 10; 29(3):175-81. PubMed ID: 16931896
    [Abstract] [Full Text] [Related]

  • 20. Changes following parathyroidectomy in hemodialyzed patients.
    Berland Y, Charhon S, Olmer M, Meunier PJ.
    Adv Exp Med Biol; 1984 Jan 10; 178():241-52. PubMed ID: 6507159
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.